These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8647788)

  • 1. Use of serotonin selective reuptake inhibitors in geriatric depression.
    Newhouse PA
    J Clin Psychiatry; 1996; 57 Suppl 5():12-22. PubMed ID: 8647788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM
    Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of SSRIs in panic disorder.
    Sheehan DV; Harnett-Sheehan K
    J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to an open trial of a second SSRI in major depression.
    Joffe RT; Levitt AJ; Sokolov ST; Young LT
    J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].
    Montejo AI; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Daniel E; de Dios A; de la Gándara J; Derecho J; Franco M; Gómez MJ; Macías JA; Martín T; Pérez V; Sánchez JM; Sánchez S; Vicens E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):311-21. PubMed ID: 9054202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of SSRIs in "very old" depressed nursing home residents.
    Trappler B; Cohen CI
    Am J Geriatr Psychiatry; 1998; 6(1):83-9. PubMed ID: 9469218
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    Zanardi R; Franchini L; Gasperini M; Perez J; Smeraldi E
    Am J Psychiatry; 1996 Dec; 153(12):1631-3. PubMed ID: 8942464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of newer antidepressants for panic disorder.
    Gorman JM
    J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
    Baumann P; Rochat B
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():15-21. PubMed ID: 7622807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
    Jakubovski E; Varigonda AL; Freemantle N; Taylor MJ; Bloch MH
    Am J Psychiatry; 2016 Feb; 173(2):174-83. PubMed ID: 26552940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
    Swartz JR; Miller BL; Lesser IM; Darby AL
    J Clin Psychiatry; 1997 May; 58(5):212-6. PubMed ID: 9184615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
    Carpenter LL; McDougle CJ; Epperson CN; Price LH
    Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.